Down modulation of Heymann's nephritis by mercuric chloride.

The time course of Heymann's nephritis (HN), assessed on proteinuria and immunomorphology, has been compared in Lewis (LEW) rats immunized with BB alone (group A) or injected with HgCl2 and subsequently immunized in a similar manner (group B). Whereas all rats from group A developed typical HN characterized by heavy proteinuria and abundant glomerular immune deposits, rats from group B did not develop or developed a markedly attenuated form of HN; proteinuria was never detectable, immune deposits were absent or minimal. No abnormalities were found in rats injected with HgCl2 alone. In order to explain our findings, we have studied the glomerular and tubular expression of the 330 kD nephritogenic glycoprotein (gp330) as well as the corresponding antibody response. In rats receiving HgCl2, gp330 was normally expressed on BB and glomerular epithelial cells as indicated by in vitro and in vivo binding of anti-gp330 antibodies, but titers of anti-BB and anti-gp330 antibodies were considerably lower than in group A control rats. These findings therefore suggest that HgCl2 acts by its immunodepressive effect recently related to an increase in T suppressor cells. This effect is paradoxical since HgCl2 induces autoimmunity in Brown-Norway rats, and we suggest that it may be akin to observations reported in clinical practice where drugs may be immunostimulatory in some patients and immunodepressive in others. The mercury model may therefore represent a unique tool to evaluate the relationship between genetics and drug-induced immune dysregulation.